NO941179L - Heteroarylaminer som nye acetylcholinesterase-inhibitorer - Google Patents

Heteroarylaminer som nye acetylcholinesterase-inhibitorer

Info

Publication number
NO941179L
NO941179L NO941179A NO941179A NO941179L NO 941179 L NO941179 L NO 941179L NO 941179 A NO941179 A NO 941179A NO 941179 A NO941179 A NO 941179A NO 941179 L NO941179 L NO 941179L
Authority
NO
Norway
Prior art keywords
heteroberlamines
acetylcholinesterase inhibitors
novel acetylcholinesterase
novel
inhibitors
Prior art date
Application number
NO941179A
Other languages
English (en)
Other versions
NO941179D0 (no
NO308533B1 (no
Inventor
Yuhpyng Liang Chen
Arthur Adam Nagel
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO941179L publication Critical patent/NO941179L/no
Publication of NO941179D0 publication Critical patent/NO941179D0/no
Publication of NO308533B1 publication Critical patent/NO308533B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Control Of Indicators Other Than Cathode Ray Tubes (AREA)
  • Control Of El Displays (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO941179A 1991-10-03 1994-03-30 Heteroarylaminer, anvendelse derav og farmasøytisk preparat NO308533B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77128391A 1991-10-03 1991-10-03
PCT/US1992/007230 WO1993007140A1 (en) 1991-10-03 1992-08-31 Heteroaryl amines as novel acetyl cholinesterase inhibitors

Publications (3)

Publication Number Publication Date
NO941179L true NO941179L (no) 1994-03-30
NO941179D0 NO941179D0 (no) 1994-03-30
NO308533B1 NO308533B1 (no) 2000-09-25

Family

ID=25091318

Family Applications (1)

Application Number Title Priority Date Filing Date
NO941179A NO308533B1 (no) 1991-10-03 1994-03-30 Heteroarylaminer, anvendelse derav og farmasøytisk preparat

Country Status (36)

Country Link
US (4) US5574046A (no)
EP (1) EP0606248B1 (no)
JP (1) JP2546785B2 (no)
KR (1) KR0170458B1 (no)
CN (1) CN1035615C (no)
AP (1) AP314A (no)
AT (1) ATE235490T1 (no)
AU (1) AU667053B2 (no)
BG (1) BG61727B1 (no)
BR (1) BR9206577A (no)
CA (1) CA2119647C (no)
CZ (1) CZ290807B6 (no)
DE (2) DE9290112U1 (no)
DK (1) DK0606248T3 (no)
EG (1) EG21481A (no)
ES (1) ES2193137T3 (no)
FI (1) FI116939B (no)
HU (1) HU225049B1 (no)
IL (1) IL103274A (no)
IS (1) IS1745B (no)
MA (1) MA22672A1 (no)
MX (1) MX9205678A (no)
NO (1) NO308533B1 (no)
NZ (1) NZ244601A (no)
OA (1) OA09895A (no)
PH (1) PH31290A (no)
PL (3) PL171984B1 (no)
PT (1) PT100917B (no)
RO (1) RO112868B1 (no)
RU (1) RU2100357C1 (no)
SG (1) SG52618A1 (no)
TW (1) TW263504B (no)
UA (1) UA41290C2 (no)
UY (1) UY23484A1 (no)
WO (1) WO1993007140A1 (no)
ZA (1) ZA927589B (no)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5620973A (en) * 1993-11-30 1997-04-15 Takeda Chemical Industries, Ltd. Tetracyclic condensed heterocyclic compounds and their use
EP0976404A3 (en) * 1998-07-30 2001-06-27 Pfizer Products Inc. A pharmaceutical composition for the prevention and treatment of diseases of cognitive dysfunction in a mammal
US6218383B1 (en) 1998-08-07 2001-04-17 Targacept, Inc. Pharmaceutical compositions for the prevention and treatment of central nervous system disorders
KR100639543B1 (ko) 1998-09-30 2006-10-31 다케다 야쿠힌 고교 가부시키가이샤 방광 배출력 개선제
CN1317276C (zh) * 2000-09-29 2007-05-23 中国科学院上海药物研究所 一类吲哚基哌啶类化合物及其制备方法和用途
CA2422717A1 (en) * 2000-10-20 2002-04-25 Biovitrum Ab 2-, 3-, 4-, or 5-substituted-n1-(benzensulfonyl)indoles and their use in therapy
EP1554271A1 (en) * 2002-10-15 2005-07-20 Rigel Pharmaceuticals, Inc. Substituted indoles and their use as hcv inhibitors
US20060014801A1 (en) * 2002-11-22 2006-01-19 The Johns Hopkins University Prevention and treatment of cognitive impairment using (R)-(-)-5-methyl-1-nicotynoyl-2-pyrazoline (MNP) and analogs
US20050267077A1 (en) * 2004-05-14 2005-12-01 Johns Hopkins University Method for improving cognitive function by co-administration of a GABAB receptor antagonist and an acetylcholinesterase inhibitor
EP1600447A1 (en) * 2004-05-28 2005-11-30 Neuropharma S.A.U. Butyrylcholinesterase selective inhibitors
CA2569887A1 (en) 2004-06-09 2005-12-22 Glaxo Group Limited Pyrrolopyridine derivatives
EP1827468B1 (en) * 2004-12-23 2012-08-22 Curaxis Pharmaceutical Corporation Acetylcholinesterase Inhibitors and leuprolide acetate for the treatment of Alzheimer's disease
CN1808106B (zh) * 2005-01-21 2010-11-24 中国科学院上海药物研究所 一种用核磁共振筛选乙酰胆碱酯酶抑制剂的方法
US8846315B2 (en) 2008-08-12 2014-09-30 Zinfandel Pharmaceuticals, Inc. Disease risk factors and methods of use
EA021399B1 (ru) 2008-08-12 2015-06-30 Зинфандел Фармасьютикалз, Инк. Способ идентификации факторов риска заболеваний
CN101503414B (zh) * 2009-03-04 2013-10-30 沈阳药科大学 噻唑并[3,2-b]-1,2,4-三嗪衍生物及其应用
NO2482815T3 (no) * 2009-10-02 2018-09-29
CN102905532A (zh) 2010-02-09 2013-01-30 约翰斯.霍普金斯大学 用于改善认知功能的方法和组合物
PE20181179A1 (es) 2011-01-10 2018-07-20 Zinfandel Pharmaceuticals Inc Metodos y productos de farmaco para tratar enfermedad de alzheimer
EP2919788A4 (en) 2012-11-14 2016-05-25 Univ Johns Hopkins METHODS AND COMPOSITIONS FOR THE TREATMENT OF SCHIZOPHRENIA
AU2014211489A1 (en) 2013-01-29 2015-08-13 Avexxin As Antiinflammatory and antitumor 2-oxothiazoles and 2-oxothiophenes compounds
AU2014228512A1 (en) 2013-03-15 2015-10-01 Agenebio, Inc. Methods and compositions for improving cognitive function
WO2014144663A1 (en) 2013-03-15 2014-09-18 The Johns Hopkins University Methods and compositions for improving cognitive function
CN103333163A (zh) * 2013-07-09 2013-10-02 广州中医药大学 一种苯并呋喃类衍生物及其制备方法和应用
GB201413695D0 (en) 2014-08-01 2014-09-17 Avexxin As Compound
CN112843005B (zh) 2015-05-22 2023-02-21 艾吉因生物股份有限公司 左乙拉西坦的延时释放药物组合物
GB201604318D0 (en) 2016-03-14 2016-04-27 Avexxin As Combination therapy
CN107141266B (zh) * 2017-06-28 2019-04-09 佳木斯大学附属第一医院 一种用于治疗阿尔茨海默病的杂环化合物及其制备方法
CN115466211B (zh) * 2022-06-09 2024-02-23 中国人民解放军空军军医大学 一种n-苯基喹啉-4-胺类化合物及其应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL100127C (no) * 1954-04-28
FR2334358A1 (fr) * 1975-12-12 1977-07-08 Sogeras Nouveaux medicaments derives de l'indole
US4122265A (en) * 1976-05-21 1978-10-24 Hoffmann-La Roche Inc. Derivatives of 3-phenylisoindole-1-carboxylic acid
ZA815541B (en) * 1980-08-12 1983-03-30 Glaxo Group Ltd Heterocyclic compounds
GB8615562D0 (en) * 1986-06-25 1986-07-30 Maggioni Farma Aminoalcohols
KR910006138B1 (ko) * 1986-09-30 1991-08-16 에자이 가부시끼가이샤 환상아민 유도체
FI95572C (fi) * 1987-06-22 1996-02-26 Eisai Co Ltd Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi
IT1226100B (it) * 1988-07-07 1990-12-10 Dompe Farmaceutici Spa Derivati benzimidazolici farmacologicamente attivi.
FR2640266B2 (fr) * 1988-07-12 1992-07-10 Synthelabo Derives de (hydroxy-1 piperidinyl-2 alkyl) indolones-2, quinoleinones-2, benzo(b)azepinones-2 et benzimidazolones-2, leur preparation et leur application en therapeutique
US4908372A (en) * 1988-10-13 1990-03-13 Merrell Dow Pharmaceuticals Inc. Antihistaminic piperidinyl benzimidazoles
JP2969359B2 (ja) * 1989-01-13 1999-11-02 武田薬品工業株式会社 環状アミン化合物
US5064840A (en) * 1989-08-03 1991-11-12 Merrell Dow Pharmaceuticals Anti-psychotic piperidylbenzimidazole compounds
TW197442B (no) * 1990-02-08 1993-01-01 Pfizer
US5116846A (en) * 1990-03-28 1992-05-26 Du Pont Merck Pharmaceutical Company N-aralkyl piperidine derivatives as psychotropic drugs
TW197435B (no) * 1990-11-22 1993-01-01 Takeda Pharm Industry Co Ltd
NZ243065A (en) * 1991-06-13 1995-07-26 Lundbeck & Co As H Piperidine derivatives and pharmaceutical compositions
CA2129995C (en) * 1992-02-13 2000-04-11 Albert A. Carr Piperidinyl thiacyclic derivatives
TW226019B (no) * 1992-03-23 1994-07-01 Sankyo Co

Also Published As

Publication number Publication date
DE69232976T2 (de) 2003-10-02
IS1745B (is) 2000-05-18
CZ78594A3 (en) 1995-07-12
FI116939B (fi) 2006-04-13
CN1071166A (zh) 1993-04-21
PT100917B (pt) 1999-07-30
PL171669B1 (en) 1997-06-30
DK0606248T3 (da) 2003-06-23
WO1993007140A1 (en) 1993-04-15
SG52618A1 (en) 1998-09-28
HU9400952D0 (en) 1994-06-28
CN1035615C (zh) 1997-08-13
HUT70544A (en) 1995-10-30
BR9206577A (pt) 1995-10-10
US5574046A (en) 1996-11-12
KR0170458B1 (ko) 1999-02-18
IL103274A0 (en) 1993-02-21
IL103274A (en) 1996-11-14
CA2119647A1 (en) 1993-04-15
TW263504B (no) 1995-11-21
US6124321A (en) 2000-09-26
DE69232976D1 (de) 2003-04-30
EP0606248A1 (en) 1994-07-20
MA22672A1 (fr) 1993-07-01
PL171693B1 (pl) 1997-06-30
ATE235490T1 (de) 2003-04-15
AP314A (en) 1994-02-04
RU2100357C1 (ru) 1997-12-27
UA41290C2 (uk) 2001-09-17
CA2119647C (en) 1998-08-04
AU667053B2 (en) 1996-03-07
EG21481A (en) 2001-11-28
MX9205678A (es) 1993-04-01
NO941179D0 (no) 1994-03-30
PL171984B1 (pl) 1997-07-31
ES2193137T3 (es) 2003-11-01
BG98689A (bg) 1995-03-31
RO112868B1 (ro) 1998-01-30
FI941518A (fi) 1994-03-31
JP2546785B2 (ja) 1996-10-23
OA09895A (en) 1995-09-15
UY23484A1 (es) 1993-03-11
US20020049210A1 (en) 2002-04-25
US6303633B1 (en) 2001-10-16
JPH06510788A (ja) 1994-12-01
HU225049B1 (en) 2006-05-29
PT100917A (pt) 1993-11-30
NO308533B1 (no) 2000-09-25
FI941518A0 (fi) 1994-03-31
NZ244601A (en) 1995-03-28
IS3919A (is) 1993-04-04
AU2519692A (en) 1993-05-03
CZ290807B6 (cs) 2002-10-16
ZA927589B (en) 1994-04-05
EP0606248B1 (en) 2003-03-26
PH31290A (en) 1998-07-06
BG61727B1 (bg) 1998-04-30
AP9200421A0 (en) 1992-10-31
DE9290112U1 (de) 1994-06-01

Similar Documents

Publication Publication Date Title
NO941179D0 (no) Heteroarylaminer som nye acetylcholinesterase-inhibitorer
NO973764L (no) Nye dipeptidamidiner som trombin-inhibitorer
FI940393A0 (fi) Kinatsoliinijohdannaiset asetyylikoliiniesteraasi-inhibiittoreina
FI933167A (fi) N-alkylkinuklidiniumsalter som substans-p antagonister
NO923533D0 (no) Nye 5-amino-4-hydroksyheksansyrederivater som terapeutika
NO920328D0 (no) Nye sulfonylurinstoffer
NO922673D0 (no) Nye hiv proteaseinhibitorer
FI922973A (fi) Tokoferolblandning foer anvaendning som antioxidant foer krusmyntolja i tuggummi
FI940469A (fi) Kinoliinijohdannaisia immunostimulantteina
DK0509974T3 (da) Nye aktive forbindelser
DK0409676T3 (da) Acetylcholinesterase-inhibitorer
NO923382D0 (no) Nye, terapeutisk virksomme benzopyranderivater
NO922167D0 (no) Aminodukter som korrosjonshemmere
NO922243L (no) Nye cefem-forbindelser
DK69591D0 (da) Nye mikroorganismer
FI923555A (fi) Foerfarande foer framstaellning av mattor som bestaor av minst tvao med varandra bundna skikt
FI930342A0 (fi) Pentapeptider som reglerar immun- och nervsystem
NO924900L (no) Nye tiazoler
DK186791D0 (da) Nye enzymer
NO921706L (no) Nye 2-merkaptomethylen-tetrahydronafthalen- og indan-2-carboxamidderivater som enkefalinaseinhibitorer
NO912574D0 (no) Piperidinylforbindelser og deres anvendelse som tilsetningsmidler.
NO942051D0 (no) Nye tiosemikarbazontioner
NO940633D0 (no) Nye forbindelser
NO952939D0 (no) Nye substituerte tiosemikarbazontioner
NO922191L (no) Nye thrombininhibitorer